M. Guerrero

发表

Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture–recapture method

E. de Ramón, O Fernández, M. Romero, 2012, Multiple sclerosis.

Association of CD28 IVS3 +17T/C polymorphism with soluble CD28 in rheumatoid arthritis

M. Guerrero, J. Guadalajara, Guadalajara Guadalajara, 2011 .

Acute meningoencephalitis as the sole manifestation of Q fever

C. Maroto, R. González-Maldonado, M. Guerrero, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Allelic expression and interleukin-2 polymorphisms in multiple sclerosis

A. Alcina, F. Matesanz, M. Collado-Romero, 2001, Journal of Neuroimmunology.

Three-year study of antibody toBorrelia burgdorferi in Southern Spain

E. Padilla, J. Gutiérrez, G. Piédrola, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients.

J. Carrillo, J. Gutiérrez, M. Guerrero, 2011, Diagnostic microbiology and infectious disease.

Multiple Sclerosis and Human Herpesvirus 6

J. Gutiérrez, G. Piédrola, M. Guerrero, 2002, Infection.

Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months

M. Pinto-Medel, L. Leyva, V. Fernández, 2011, Multiple sclerosis.

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain)

M. Pinto-Medel, L. Leyva, M. Guerrero, 2009, Journal of Neurology.

HLA class II and response to interferon‐beta in multiple sclerosis

C. Mayorga, L. Leyva, V. Fernández, 2005, Acta neurologica Scandinavica.

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

D. Pozo, G. Izquierdo, A. Hmadcha, 2018, PloS one.

IL2RA/CD25 Gene Polymorphisms: Uneven Association with Multiple Sclerosis (MS) and Type 1 Diabetes (T1D)

María M. Abad-Grau, M. M. Abad-Grau, A. Alcina, 2009, PloS one.

OAS1 gene haplotype confers susceptibility to multiple sclerosis.

A. Alcina, F. Matesanz, J. López-Guerrero, 2006, Tissue antigens.

Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients

M. Blanca, C. Mayorga, L. Leyva, 2001, Journal of Neurology.

IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility

A. Alcina, F. Matesanz, R. Milne, 2007, Journal of Neurology.

Antibodies to Borrelia burgdorferi in European populations

J. Gutiérrez, G. Piédrola, M. Soto, 2000, Journal of clinical laboratory analysis.

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

L. Peltonen, A. Alcina, F. Matesanz, 2008, Journal of Medical Genetics.

The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis

A. Alcina, F. Matesanz, R. Milne, 2008, Journal of Neuroimmunology.

Gene expression in IFNß signalling pathway differs between monocytes, CD4 and CD8 T cells from MS patients

B. Oliver-Martos, M. Pinto-Medel, L. Leyva, 2011, Journal of Neuroimmunology.

Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß

B. Oliver-Martos, M. Pinto-Medel, P. Urbaneja, 2017, PloS one.

Validation of the spanish version of the multiple sclerosis international quality of life (musiqol) questionnaire

P. Auquier, E. V. di Cantogno, V. Fernández, 2011, BMC neurology.

IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response

Fuencisla Matesanz, Maria Fedetz, Laura Leyva, 2005, Journal of Neuroimmunology.

The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study

E. de Ramón, L. Leyva, V. Fernández, 2011, Multiple sclerosis.

Combination therapy with interferon Beta-1b and azathioprine in secondary progressive multiple sclerosis

A. Capdevila, E. de Ramón, C. Mayorga, 2002, Journal of Neurology.

The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis.

A. Alcina, F. Matesanz, M. Fedetz, 2008, Tissue antigens.

The −174/−597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis

A. Alcina, F. Matesanz, Javier Martín, 2001, Journal of the Neurological Sciences.

Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population.

A. Alcina, F. Matesanz, G. Izquierdo, 2009, Tissue antigens.

Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis

J. González, A. Alcina, F. Matesanz, 2010, European Journal of Human Genetics.

Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population.

A. Alcina, F. Matesanz, M. Fedetz, 2009, Tissue Antigens.